Who we are

evodia is a private investment company invested in sustainable projects and companies in the European healthcare sector. The conviction that the disruptive power of digital innovations will have a positive effect on our health care systems, is driving our decisions.

What we do

evodia has been an investor in the health care market since 2005. We have a deep network in the European health care market and can lever this into our projects. We support young companies specializing in the sustainable change of the health care market through digitization. Depending on the project, this can include:

- Support in the area of revenue models and reimbursement strategies

- Networking

- Businesscoaching

- Advisory boards

- Internationalization strategies

Were we have invested

Sanvartis Group GmbH

Since 2005, we have been part of the Sanvartis Group and have significantly contributed to the successful development of the company.


Coldplasmatech GmbH
The Coldplasmatech GmbH is a startup from Greifswald, which is engaged in the use of cold plasma in medicine in recent years. As a multiple award winner, e.g. the German Innovation Award 2018, it has the potential to fundamentally improve wound care. As an early-stage investor, evodia has been involved in CPT since the end of 2016 and supports the founders in their go-to-market strategy.



Fosanis GmbH

Fosanis develops  the App mika, which helps cancer patients to learn more about their disease.

Find more:



Climedo Health GmbH

Climedo is a Munich-based Start-up, which develops a new plattform for clinical research.

Find more:



elona health GmbH
Elona is a Düsseldorf-based start-up that enables psychotherapists to digitalise their therapy and help patients to improve their chances of recovery.

derma2go AG
Derma2go is a teledermatology provider from Switzerland that connects patients with leading experts from renowned university hospitals and medical practices. Together with a team of professors, leading dermatologists and university hospitals, derma2go provides patients with high-quality online advice on skin diseases, creating access to first-class dermatological expertise across Europe.